Dr Thomas van Sloten, MD
Increasing connections between physical health and depressive symptoms continue to be found in the psychiatric world, making the distinction between mind and bod
As the number of new hepatitis C virus infections continues to rise in the United States, rapid diagnosis and treatment of high-risk patients is more important than ever. In this Q&A, Benjamin Eckhardt, MD,...
Comorbidities are a large part of the disease burden for people living with HIV. A recent study aimed to examine the prevalence of both high-risk and functional comorbidities in this patient population....
In this Q&A, Sat Bir S. Khalsa, PhD, answered our questions about his team’s study that evaluated the efficacy of yoga vs cognitive behavioral therapy vs stress education for the treatment of generalized...
In a recent study, researchers examined how chronic kidney disease care differed among patients of different races and ethnicities. Lead study author Chi Chu, MD, MAS, answered our questions on his team’s...
In this Q&A, Monica Gandhi, MD, MPH, discusses interventions to address the health care disparities that exist along the care continuum for certain patient populations who are at-risk for HIV...
In this Q and A, Rebecca Sherman, AuD, answers our questions on the importance of monitoring hearing as a patient gets older, how hearing loss affects the brain, and the link between untreated hearing loss...
In this Q&A, Sara Reece, PharmD, CDCES, discusses the use of GLP-1 agonists and SGLT-2 inhibitors to improve cardiovascular and renal outcomes in patients with type 2 diabetes.
